Baijin Life Science Holdings Limited risk profile
76 Stretched several inputs deteriorating together
Measured 21 October 2026 from 1466.HK's filed statements. Recomputed nightly.
76 (Stretched), driven by Cash conversion at 100, over 5 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 58 | Elevated | Volatile | One-year price volatility — 101.8% |
| Operating pressure | 83 | Acute | Worsening | Costs outgrowing revenue — +39.8 percentage points |
| Cash conversion | 100 | Acute | Stable | Capital spending against operating cash — -2.10x |
| Leverage and coverage | 39 | Normal | Easing | Interest cover — -40.37x |
| Competitive position | 82 | Acute | Stable | Operating-margin gap against peers — -57.8 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Cyclical companies with a risk reading
Amazon.com Inc 48Tesla Inc 46Home Depot Inc 52Alibaba Group Holding Ltd 69Toyota Motor Corporation 38LVMH Moët Hennessy - Louis Vuitton Société Européenne 45LVMH Moet Hennessy Louis Vuitton SE 39McDonald`s Corp 30TJX Companies Inc 43Hermes International SCA 22HERMES INTL 25Fast Retailing Co., Ltd. 29
Financials, valuation and price history for Baijin Life Science Holdings Limited